Attentional Biases, Reward Sensitivity, and Cognitive Control in Adults With Bipolar Disorder and Different Psychiatric Comorbidities: An Eye-Tracking Study

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The purpose of this study is to use eye-tracking technology to study attentional biases, reward sensitivity, and cognitive control in adult patients with bipolar disorder with or without anxiety and/or substance use disorder comorbidity.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

• Inclusion Criteria for Group 1:

⁃ i. Male or female, age 18 or older

⁃ ii. Meets diagnostic criteria for lifetime bipolar I or II disorder according to Diagnostic and Statistical Manual-5 (DSM-5) criteria, as confirmed by the Mini International Neuropsychiatric Interview (MINI)

⁃ iii. Currently in a depressive episode or currently in remission from a mood episode

⁃ iv. Young Mania Rating Scale total score ≤ 8

⁃ v. In the opinion of the investigator, capable of understanding and complying with protocol requirements

⁃ vi. In the opinion of the investigator, has the competency to understand and sign the informed consent

⁃ vii. Subject is compliant with taking psychiatric medication(s) per the investigator's discretion

⁃ a. Inclusion Criteria for Group 2:

⁃ i. Male or female, age 18 or older

⁃ ii. Meets diagnostic criteria for lifetime bipolar I or II disorder according to DSM-5 criteria, as confirmed by the Mini International Neuropsychiatric Interview (MINI)

⁃ iii. Currently in a depressive episode or currently in remission from a mood episode

⁃ iv. Meets diagnostic criteria for a current anxiety disorder (generalized anxiety disorder, panic disorder, and/or social phobia) as confirmed by the Mini International Neuropsychiatric Interview (MINI)

⁃ v. Hamilton Anxiety Rating Scale total score ≥ 18

⁃ vi. Young Mania Rating Scale total score ≤ 8

⁃ vii. In the opinion of the investigator, capable of understanding and complying with protocol requirements

⁃ viii. In the opinion of the investigator, has the competency to understand and sign the informed consent

⁃ ix. Subject is compliant with taking psychiatric medication(s) per the investigator's discretion

⁃ a. Inclusion Criteria for Group 3:

⁃ i. Male or female, age 18 or older

⁃ ii. Meets diagnostic criteria for lifetime bipolar I or II disorder according to the DSM-5 criteria, as confirmed by the Mini International Neuropsychiatric Interview (MINI)

⁃ iii. Meets diagnostic criteria for a substance use disorder within the last 3 months

⁃ iv. Meets diagnostic criteria for a current anxiety disorder (generalized anxiety disorder, panic disorder, and/or social phobia) as confirmed by the Mini International Neuropsychiatric Interview (MINI)

⁃ v. Currently in a depressive episode or currently in remission from a mood episode

⁃ vi. Hamilton Anxiety Rating Scale total score ≥ 18

⁃ vii. Young Mania Rating Scale total score ≤ 8

⁃ viii. In the opinion of the investigator, capable of understanding and complying with protocol requirements

⁃ ix. In the opinion of the investigator, has the competency to understand and sign the informed consent

⁃ x. Subject is compliant with taking psychiatric medication(s) per the investigator's discretion

⁃ a. Inclusion Criteria for Group 4:

⁃ i. Male or female, age 18 or older

⁃ ii. Meets diagnostic criteria for lifetime bipolar I or II disorder according to the DSM-5 criteria, as confirmed by the Mini International Neuropsychiatric Interview (MINI)

⁃ iii. Meets diagnostic criteria for a substance use disorder within the last 3 months

⁃ iv. Currently in a depressive episode or currently in remission from a mood episode

⁃ v. Young Mania Rating Scale total score ≤ 8

⁃ vi. Hamilton Anxiety Rating Scale total score ≤ 12

⁃ vii. In the opinion of the investigator, capable of understanding and complying with protocol requirements

⁃ viii. In the opinion of the investigator, has the competency to understand and sign the informed consent

⁃ ix. Subject is compliant with taking psychiatric medication(s) per the investigator's discretion

• Inclusion criteria for Group 5:

⁃ i. Male or female, age 18 or older

⁃ ii. In the opinion of the investigator, capable of understanding and complying with protocol requirements

⁃ iii. In the opinion of the investigator, has the competency to understand and sign the informed consent

⁃ iv. Physically healthy as determined by research psychiatrist

⁃ v. Without any current and/or lifetime psychiatric disorder as confirmed by the Mini International Neuropsychiatric Interview (MINI)

Locations
United States
Ohio
University Hospitals Cleveland Medical Center - Mood Disorders Program
RECRUITING
Cleveland
Contact Information
Primary
Nicole Jones
mdp@uhhospitals.org
216/844-2862
Time Frame
Start Date: 2019-03-27
Estimated Completion Date: 2026-09-01
Participants
Target number of participants: 100
Treatments
Bipolar without Anxiety or Substance Use Disorder
Subjects who are diagnosed with bipolar disorder but do not have any current anxiety or substance use disorders
Bipolar disorder with a current anxiety disorder only
Subjects who are diagnosed with bipolar disorder and a current anxiety disorder (generalized anxiety disorder, panic disorder, and/or social phobia) but not a current substance use disorders
Bipolar disorder with a current anxiety disorder and a current
Subjects who are diagnosed with bipolar disorder and a current anxiety disorder (generalized anxiety disorder, panic disorder, and/or social phobia) AND a current substance use disorders
Bipolar disorder with a current substance use disorder only
Subjects who are diagnosed with bipolar disorder \& a substance use disorders but not a current anxiety disorder
Healthy Volunteers
Related Therapeutic Areas
Sponsors
Leads: University Hospitals Cleveland Medical Center

This content was sourced from clinicaltrials.gov